HomeMy WebLinkAbout20221831.tiffRESOLUTION
RE: APPROVE FDP COST REIMBURSEMENT SUBAWARD AGREEMENT FOR
HPV FREE COLORADO PROJECT AND AUTHORIZE CHAIR TO SIGN AND SUBMIT
ELECTRONICALLY - DENVER HEALTH AND HOSPITAL AUTHORITY (DHHA)
WHEREAS, the Board of County Commissioners of Weld County, Colorado, pursuant to
Colorado statute and the Weld County Home Rule Charter, is vested with the authority of
administering the affairs of Weld County, Colorado, and
WHEREAS, the Board has been presented with a FDP Cost Reimbursement Subaward
Agreement for the HPV (Human Papillomavirus) Free Colorado Project between the County of
Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on
behalf of the Department of Public Health and Environment, and Denver Health and Hospital
Authority (DHHA), commencing July 1, 2022, and ending June 30, 2023, with further terms and
conditions being as stated in said agreement, and
WHEREAS, after review, the Board deems it advisable to approve said agreement, a copy
of which is attached hereto and incorporated herein by reference.
NOW, THEREFORE, BE IT RESOLVED by the Board of County Commissioners of Weld
County, Colorado, that the FDP Cost Reimbursement Subaward Agreement for the HPV (Human
Papillomavirus) Free Colorado Project between the County of Weld, State of Colorado, by and
through the Board of County Commissioners of Weld County, on behalf of the Department of
Public Health and Environment, and Denver Health and Hospital Authority (DHHA), be, and
hereby is, approved.
BE IT FURTHER RESOLVED by the Board that the Chair be, and hereby is, authorized
to electronically sign and submit said agreement.
The above and foregoing Resolution was, on motion duly made and seconded, adopted
by the following vote on the 27th day of June, A.D., 2022
BOARD OF COUNTY COMMISSIONERS
WELL COUNTY, COLORADO
ATTEST: d ) A.4
cott K. James, Chair
Weld County Clerk to the Board
BY:
I\J
Deputy Clerk to the Boar
Mi
Perry L. B
APED
County ' ttorney
Date of signature: 7f7/22,
cc•.HL(T6)
7/'s /z2
, Pro-T.a
teve Moreno
Lori Saine
2022-1831
HL0054
Con -Iva Cd- I D# l00 S
Memorandum
TO: Scott James, Chair
Board of County Commissioners
FROM: Mark Lawley, Executive Director
Department of Public Health & Environmer
DATE: June 20, 2022
SUBJECT: Alliance for HPV Free Colorado
Subaward Agreement with Denver
Health & Hospital Authority
For the Board's approval is the FY22-23 HPV Free Colorado Subaward Agreement between
the Denver Health and Hospital Authority (DHHA) and the Weld County Board of
Commissioners for the benefit and use of the Weld County Department of Public Health
and Environment (WCDPHE).
The Alliance for HPV Free Colorado is a collaborative project funded by the Cancer
Cardiovascular and Chronic Pulmonary Disease Grants Program working to decrease rates
of the Human Papillomavirus (HPV) in a 15 -county region across Colorado. The goal is to
implement a multidisciplinary, socioecological approach that results in a sustainable
increase in completion of the HPV vaccine series for eleven to seventeen -year -olds.
These funds will be used to promote and champion HPV vaccine education and awareness,
implement a health systems approach to increase adherence to national HPV vaccination
guidelines among practices and providers, implement a targeted communication plan for
parents of teens, and measure HPV vaccination rates, which have increased in Weld
County since our participation in this project. Healthy People 2030 has a goal to increase
the proportion of adolescents who receive the recommended doses of HPV vaccine to 80%.
Currently, approximately 42% of teens aged 11-17 years are fully vaccinated against HPV
in Weld County and 46% state-wide, which are both increases since last year. Through
collaboration with our community and regional partners, which includes standardized
messaging, we can help continue to improve these statistics.
With the approval of this contract, Weld County will be reimbursed up to $26,738 by
Denver Health and Hospital Authority for the project term of July 1, 2022, through June
30, 2023. No new FTE will be required to perform the deliverables under this collaborative
agreement with DHHA; they can be met with existing staff.
Assistant Weld County Attorney, Karin McDougal, has reviewed this agreement and
determined that its terms are acceptable.
Four of the five Board members approved placement of this agreement on the Board's agenda
via pass -around dated June 17, 2022.
I recommend approval of this HPV Free Colorado Subaward Agreement with "T"-
2022-1831
out 7.—/ H -L0054
BOARD OF COUNTY COMMISSIONERS
PASS -AROUND REVIEW
TITLE: Alliance for HPV Free Colorado Subaward Agreement with Denver Health & Hospital Authority
DEPARTMENT: PUBLIC HEALTH & ENVIRONMENT DATE: June 17, 2022
PERSON REQUESTING: Mark Lawley, Executive Director
Brief description of the problem/issue:
Enclosed for the Board's review and approval for placement on the agenda is the FY22-23 HPV Free Colorado
Subaward Agreement between the Denver Health and Hospital Authority (DHHA) and the Weld County Board of
Commissioners for the benefit and use of the Weld County Department of Public Health and Environment
(WCDPHE).
The Alliance for HPV Free Colorado is a collaborative project funded by the Cancer Cardiovascular and Chronic
Pulmonary Disease Grants Program working to decrease rates of the Human Papillomavirus (HPV) in a 15 -county
region across Colorado. The goal is to implement a multidisciplinary, socioecological approach that results in a
sustainable increase in completion of the HPV vaccine series for eleven to seventeen -year -olds.
These funds will be used to promote and champion HPV vaccine education and awareness, implement a health
systems approach to increase adherence to national HPV vaccination guidelines among practices and providers,
implement a targeted communication plan for parents of teens, and measure HPV vaccination rates, which have
increased in Weld County since our participation in this project. Healthy People 2030 has a goal to increase the
proportion of adolescents who receive the recommended doses of HPV vaccine to 80%. Currently, approximately 42%
of teens aged 11-17 years are fully vaccinated against HPV in Weld County and 46% state-wide, which are both
increases since last year. Through collaboration with our community and regional partners, which includes
standardized messaging, we can help continue to improve these statistics.
With the approval of this contract, Weld County will be reimbursed up to $26,738 by Denver Health and Hospital
Authority for the project term of July 1, 2022, through June 30, 2023. No new FTE will be required to perform the
deliverables under this collaborative agreement with DHHA, they can be met with existing staff.
This contract has been sent to Assistant Weld County Attorney, Karin, McDougal, for review and we will await her
approval prior to placement on the Board's agenda.
What options exist for the Board? (Include consequences, impacts, costs, etc. of options):
Approval of this contract with DHHA will provide funding to allow WCDPHE to be part of the solution to increase
HPV vaccination rates among eleven to seventeen -year -olds in Weld County and Colorado.
Declining this contract will result in lower than acceptable HPV vaccination rates for Weld County and Colorado
and as a result, possibly an increase in preventable HPV cancers.
Recommendation: I recommend approval of this HPV Free Colorado Subaward Agreement with DHHA.
Approve Schedule
Recommendation Work Session Other/Comments:
Perry L. Buck
Mike Freeman, Pro-Tem
Scott K. James, Chair
Steve Moreno
Lori Saine
DocuSign.
Certificate Qf Completion
Envelope Id:63C1C5769AFB49DBB750D569B4FB2ED7
Subject: Please DocuSign: A18-0055-S008-A03_5269_NE.pdf
Source Envelope:
Document Pages: 15
Certificate Pages: 5
AutoNav: Enabled
Envelopeld Stamping: Enabled
Time Zone: (UTC-07:00) Mountain Time (US & Canada)
Status: Original
6/10/2022 2:22:07 PM
Scott K. James
bocc-contracts@weldgov.com
Chair, Commissioners
Security Level: Email, Account Authentication
(None)
Electronic Record and Signature Disclosure:
Accepted: 6/23/2022 5:08:32 PM
ID: 8de3f7f3-321 c-43dd-af66-9db7a29a76c2
Tanya Geiser
tgeiser@co.weld.co.us
Security Level: Email, Account Authentication
(None)
Electronic Record and Signature Disclosure:
Accepted: 6/10/2022 4:59:33 PM
ID:165e3107-7caa-410d-ad52-10ee9b3e86a2
Envelope Sent
Certified Delivered
Signing Complete
Completed
Signatures: 1
Initials: 0
Holder: Sparo Contracts
Sparo_Contracts@dhha.org
ignature
l—DocuSigr, d by:
coif . jait.s
"—E04467D642AE4A7...
Signature Adoption: Pre -selected Style
Signed by link sent to bocc-contracts@weldgov.com
Using IP Address: 204.133.39.9
Signature
Status
Status
Status
COPIED
Hashed/Encrypted
Security Checked
Security Checked
Security Checked
Status: Completed
Envelope Originator:
Sparo Contracts
777 Bannock
Denver, CO 80204
Sparo_Contracts@dhha.org
IP Address: 205.170.235.246
Location: DocuSign
Timestamp
Sent: 6/23/2022 4:38:01 PM
Viewed: 6/23/2022 5:08:32 PM
Signed: 6/27/2022 10:23:42 AM
Timestamp
Timestamp
Timestamp
Timestamp
Timestamp
Timestamp
Sent: 6/23/2022 4:38:03 PM
Timestamp
Timestamps
6/10/2022 4:26:18 PM
6/23/2022 5:08:32 PM
6/27/2022 10:23:42 AM
6/27/2022 10:23:42 AM
Payment Events Status
Electronic Record and Signature Disclosure
Timestamps
Electronic Record and Signature Disclosure created on: 5/22/2018 3:40:08 PM
Parties agreed to: Scott K. James, Tanya Geiser
ELECTRONIC RECORD AND SIGNATURE DISCLOSURE
From time to time, Denver Health and Hospitals Authority Inc - Legal (we, us or Company) may
be required by law to provide to you certain written notices or disclosures. Described below are
the terms and conditions for providing to you such notices and disclosures electronically through
your DocuSign, Inc. (DocuSign) Express user account. Please read the information below
carefully and thoroughly, and if you can access this information electronically to your
satisfaction and agree to these terms and conditions, please confirm your agreement by clicking
the 'I agree' button at the bottom of this document.
Getting paper copies
At any time, you may request from us a paper copy of any record provided or made available
electronically to you by us. For such copies, as long as you are an authorized user of the
DocuSign system you will have the ability to download and print any documents we send to you
through your DocuSign user account for a limited period of time (usually 30 days) after such
documents are first sent to you. After such time, if you wish for us to send you paper copies of
any such documents from our office to you, you will be charged a $0.00 per -page fee. You may
request delivery of such paper copies from us by following the procedure described below.
Withdrawing your consent
If you decide to receive notices and disclosures from us electronically, you may at any time
change your mind and tell us that thereafter you want to receive required notices and disclosures
only in paper format. How you must inform us of your decision to receive future notices and
disclosure in paper format and withdraw your consent to receive notices and disclosures
electronically is described below.
Consequences of changing your mind
If you elect to receive required notices and disclosures only in paper format, it will slow the
speed at which we can complete certain steps in transactions with you and delivering services to
you because we will need first to send the required notices or disclosures to you in paper format,
and then wait until we receive back from you your acknowledgment of your receipt of such
paper notices or disclosures. To indicate to us that you are changing your mind, you must
withdraw your consent using the DocuSign 'Withdraw Consent' form on the signing page of your
DocuSign account. This will indicate to us that you have withdrawn your consent to receive
required notices and disclosures electronically from us and you will no longer be able to use your
DocuSign Express user account to receive required notices and consents electronically from us
or to sign electronically documents from us.
All notices and disclosures will be sent to you electronically
Unless you tell us otherwise in accordance with the procedures described herein, we will provide
electronically to you through your DocuSign user account all required notices, disclosures,
authorizations, acknowledgements, and other documents that are required to be provided or made
available to you during the course of our relationship with you. To reduce the chance of you
inadvertently not receiving any notice or disclosure, we prefer to provide all of the required
notices and disclosures to you by the same method and to the same address that you have given
us. Thus, you can receive all the disclosures and notices electronically or in paper format through
the paper mail delivery system. If you do not agree with this process, please let us know as
described below. Please also see the paragraph immediately above that describes the
consequences of your electing not to receive delivery of the notices and disclosures
electronically from us.
How to contact Denver Health and Hospitals Authority Inc - Legal:
You may contact us to let us know of your changes as to how we may contact you electronically,
to request paper copies of certain information from us, and to withdraw your prior consent to
receive notices and disclosures electronically as follows:
To contact us by email send messages to: lara.miller@dhha.org
To advise Denver Health and Hospitals Authority Inc - Legal of your new e-mail address
To let us know of a change in your e-mail address where we should send notices and disclosures
electronically to you, you must send an email message to us at lara.miller@dhha.org and in the
body of such request you must state: your previous e-mail address, your new e-mail address. We
do not require any other information from you to change your email address..
In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected
in your DocuSign account by following the process for changing e-mail in DocuSign.
To request paper copies from Denver Health and Hospitals Authority Inc - Legal
To request delivery from us of paper copies of the notices and disclosures previously provided
by us to you electronically, you must send us an e-mail to lara.miller@dhha.org and in the body
of such request you must state your e-mail address, full name, US Postal address, and telephone
number. We will bill you for any fees at that time, if any.
To withdraw your consent with Denver Health and Hospitals Authority Inc - Legal
To inform us that you no longer want to receive future notices and disclosures in electronic
format you may:
i. decline to sign a document from within your DocuSign account, and on the subsequent
page, select the check -box indicating you wish to withdraw your consent, or you may;
ii. send us an e-mail to lara.miller@dhha.org and in the body of such request you must
state your e-mail, full name, IS Postal Address, telephone number, and account number.
We do not need any other information from you to withdraw consent.. The consequences
of your withdrawing consent for online documents will be that transactions may take a
longer time to process..
Required hardware and software
Operating Systems: Windows2000? or WindowsXP?
Browsers (for
SENDERS): (Internet Explorer 6.0? or above
Browsers (for
SIGNERS):
Email: !Access to a valid email account
Internet Explorer 6.0?, Mozilla FireFox 1.0, NetScape 7.2 (or above)
Screen Resolution: ,800 x 600 minimum
Enabled Security !. Allow per session cookies
Settings:
I• Users accessing the internet behind a Proxy Server must enable HTTP
1.1 settings via proxy connection
** These minimum requirements are subject to change. If these requirements change, we will
provide you with an email message at the email address we have on file for you at that time
providing you with the revised hardware and software requirements, at which time you will have
the right to withdraw your consent.
Acknowledging your access and consent to receive materials electronically
To confirm to us that you can access this information electronically, which will be similar to
other electronic notices and disclosures that we will provide to you, please verify that you were
able to read this electronic disclosure and that you also were able to print on paper or
electronically save this page for your future reference and access or that you were able to e-mail
this disclosure and consent to an address where you will be able to print on paper or save it for
your future reference and access. Further, if you consent to receiving notices and disclosures
exclusively in electronic format on the terms and conditions described above, please let us know
by clicking the 'I agree' button below.
By checking the 'I Agree' box, I confirm that:
• I can access and read this Electronic CONSENT TO ELECTRONIC RECEIPT OF
ELECTRONIC RECORD AND SIGNATURE DISCLOSURES document; and
• I can print on paper the disclosure or save or send the disclosure to a place where I can
print it, for future reference and access; and
• Until or unless I notify Denver Health and Hospitals Authority Inc - Legal as described
above, I consent to receive from exclusively through electronic means all notices,
disclosures, authorizations, acknowledgements, and other documents that are required to
be provided or made available to me by Denver Health and Hospitals Authority Inc -
Legal during the course of my relationship with you.
DocuSign Envelope ID: 15EAADD5-4411-4676-9E26-1 D85756EE4BE
FDP Cost Reimbursement Subaward Agreement
Prime Sponsor (Non-federal):
CDPHE
Pass -Through Entity (PTE):
Subrecipient:
Denver Health and Hospital Authority
Weld County Department of Public Health and Environment,
PTE PI:
Judith Shlay
Sub PI:
N/A
Prime Sponsor Award #
2021-0247 OL#4
Subaward No:
A18 -0055 -S008 -A03
Project Titie:LHPV
Free Colorado
Subaward Period of Performance (Budget Period):
Amount Funded This Action $
(USD):
26,738.00
Start: 107/01/2022 1 End:106/30/2023
Estimated Proiect Period (if incrementally f
dPrn
Incrementally Estimated Total (USD): $147,064.00 j
_ _._ .. .
Start: 107/01/2019 End:
06/30/2023
Terms and Conditions
1. PTE hereby awards a cost reimbursable subaward, as described above, to Subrecipient. The Statement of Work and
budget for this Subaward are as shown in Attachment 5. In its performance of Subaward work, Subrecipient shall be an
independent entity and not an employee or agent of PTE.
2. Subrecipient shall submit invoices not more often than monthly and not less frequently than quarterly for allowable costs
incurred. Upon the receipt of proper invoices, the PTE agrees to process payments in accordance with this Subaward
and 2 CFR 200.305. All invoices shall be submitted using Subrecipient's standard invoice, but at a minimum shall include
current and cumulative costs (including cost sharing), Subaward number, and certification, as required in 2 CFR 200.415
(a). Invoices that do not reference PTE Subaward number shall be returned to Subrecipient. Invoices and questions
concerning invoice receipt or payments shall be directed to the party's [Administrative
...... .........
Contact, shown in
Attachment 3A.
3. A final statement of cumulative costs incurred, including cost sharing, marke "FINAL" must be submitted to PTE's
[Administrative ontact, as shown in Attachment 3A, not later than 35
cays after thef
Budget,Period end date. j
The final statement of costs shall constitute Subrecipient's final financial report.
4. All payments shall be considered provisional and are subject to adjustment within the total estimated cost in the event
such adjustment is necessary as a result of an adverse audit finding against the Subrecipient.
5. Matters concerning the technical performance of this Subaward shall be directed to the appropriate party's Principal
Investigator as shown in Attachments 3A and 3B. Technical reports are required as shown in Attachment 4.
6. Matters concerning the request or negotiation of any changes in the terms, conditions or amounts cited in this
Subaward, and any changes requiring prior approval, shall be directed to each party's
Financial CContact, as
shown in Attachments 3A and 3B. Any such change made to this Subaward requires the written approval of each
party's Authorized Official, as shown in Attachments 3A and 3B.
7. The PTE may issue non -substantive changes to the Period of Performance and budget
Unilaterally
Unilateral modification shall be considered valid 14 days after receipt unless otherwise indicated by Subrecipient when
sent to Subrecipient'sfAuthorized Official
Contact, as shown in Attachment 3B.
8. Each party shall be responsible for its negligent acts or omissions and the negligent acts or omissions of its employees,
officers, or directors, to the extent allowed by law.
9. Either party may terminate this Subaward with 30 days written notice to the appropriate party's
Authorized Official
Contact, as shown in Attachments 3A and 3B. PTE shall pay Subrecipient for termination costs as allowable under
Uniform Guidance, 2 CFR 200, or 45 CFR Part 75 Appendix IX, as applicable.
10. By signing this Subaward, including the attachments hereto which are hereby incorporated by reference,
Subrecipient certifies that it will perform the Statement of Work in accordance with the terms and conditions of this
Subaward and the applicable terms of the Prime Agreement. The parties further agree that they intend this Subaward to
comply with all applicable laws, regulations and requirements.
By an Authorized Official of Pass-thrppl�Q tits
b/Z uz2 I 5:51 PM PDT
ocesiae/Iea sr6:
By an Authorized Official of Subrecipient:
6/27/2022 I 10:23 AM MDT
Bv:
N n,t 4
Sat
`—OAC0083B8 d
`EBddfi108
F
Name: Amanda Breeden, AOR
I Date
Name:
cotz K. James
Date
Title: Sr. Director, SPARO
Title:
Chair , Commissioners
(200202-J Pal
FDP OCT 2018
DocuSign Envelope ID: 15EAADD5-4411-4676-9E26-1D85756EE4BE
Attachment 1
Certifications and Assurances
Subaward Number:
A18 -0055 -S008 -A03
Certification Regarding Lobbying (2 CFR 200.450)
By signing this Subaward, the Subrecipient Authorized Official certifies, to the best of his/her knowledge and belief, that
no Federal appropriated funds have been paid or will be paid, by or on behalf of the Subrecipient, to any person for
influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer
or employee of Congress, or an employee of a Member of Congress in connection with the awarding of any
Federal contract, the making of any Federal grant, the making of any Federal loan, the entering into of any
cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Federal
contract, grant, loan, or cooperative agreement in accordance with 2 CFR 200.450.
If any funds other than Federal appropriated funds have been paid or will be paid to any person for influencing or
intending to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress,
or an employee of a Member of Congress in connection with this Federal contract, grant, loan, or cooperative agreement,
the Subrecipient shall complete and submit Standard Form -LLL, "Disclosure Form to Report Lobbying," to the PTE.
This certification is a material representation of fact upon which reliance was placed when this transaction was made
or entered into. Submission of this certification is a prerequisite for making or entering into this transaction imposed by 31
U.S.C. 1352. Any person who fails to file the required certification shall be subject to a civil penalty of not less than
$10,000 and not more than $100,000 for each such failure.
Debarment, Suspension, and Other Responsibility Matters (2 CFR 200.213 and 2 CFR 180)
By signing this Subaward, the Subrecipient Authorized Official certifies, to the best of his/her knowledge and belief that
neither the Subrecipient nor its principals are presently debarred, suspended, proposed for debarment, declared
ineligible or voluntarily excluded from participation in this transaction by any federal department or agency, in
accordance with 2 CFR 200.213 and 2 CFR 180.
Audit and Access to Records
Per 2 CFR 200.501- 200.521, Subrecipient certifies that it will provide notice of any adverse findings which impact this
Subaward and will provide access to records as required by parts 2 CFR 200.336, 200.337, and 200.201 as applicable.
If Subrecipient is not subject to the Single Audit Act, then Subrecipient will provide notice of the completion of any
required audits and provide access to such audits upon request.
Program for Enhancement of Contractor Employee Protections (41 U.S.C 4712)
Subrecipient is hereby notified that they are required to: inform their employees working on any federal award that they
are subject to the whistleblower rights and remedies of the pilot program; inform their employees in writing of employee
whistleblower protections under 41 U.S.C §4712 in the predominant native language of the workforce; and include such
requirements in any agreement made with a subcontractor or subgrantee.
The Subrecipient shall require that the language of the certifications above in this Attachment 1 be included in the award
documents for all subawards at all tiers (including subcontracts, subgrants, and contracts under grants, loans, and
cooperative agreements) and that all subrecipients shall certify and disclose accordingly.
Use of Name
Neither party shall use the other party's name, trademarks, or other logos in any publicity, advertising, or news release
without the prior written approval of an authorized representative of that party. The parties agree that each party may use
factual information regarding the existence and purpose of the relationship that is the subject of this Subaward for
legitimate business purposes, to satisfy any reporting and funding obligations, or as required by applicable law or
regulation without written permission from the other party. In any such statement, the relationship of the parties shall be
accurately and appropriately described.
DocuSign Envelope ID: 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
Attachment 2
Prime Award Terms and Conditions
Required Data Elements
The data elements required by Uniform
Guidance are incorporated! as entered.
This Subaward Is:
Research & Development
Service
Subaward Number
A18 -0055 -S008 -A03
Federal Award Issue Date FAIN
N/A
CFDA Title
CFDA No.
N/A
Key Personnel per Prime Agreement
General Terms and Conditions
By signing this Subaward, Subrecipient agrees to the following:
1. To abide by the conditions on activities and restrictions on expenditure of sponsored funds in appropriations acts that are
applicable to this Subaward to the extent those restrictions are pertinent. This includes any recent legislation noted on the
soonsor's website:
2. 2 CFR 200
3. The Sponsor's grants policy guidance, including addenda in effect as of the beginning date of the period of performance or as
amended found at:
4. Research Terms and Conditions, including any Sponsor's specific requirements found at:
wA except for the following :
a. No -cost extensions require the written approval of the PTE. Any requests for a no -cost extension shall be directed to the
Financial Contact shown in Attachment 3A, not less than 30 days prior to the desired effective date of the requested
change.
b. Any payment mechanisms and financial reporting requirements described in the applicable Sponsor Terms and Conditions and are
replaced with Terms and Conditions (1) through (4) of this Subaward; and
c. Any prior approvals are to be sought from the PTE and not the Sponsor.
d. Title to equipment as defined in 2 CFR 200.33 that is purchased or fabricated with research funds or Subrecipient cost sharing funds,
as direct costs of the project or program, shall vest in the Subrecipient subject to the conditions specified in 2 CFR 200.313.
e. Prior approval must be sought for a change in Subrecipient PI or change in Key Personnel (defined as listed in the Prime Award).
5. Treatment of program income:
Additive
This section intentionally left blank
Special Terms and Conditions:
Copyrights:
Subrecipien( grants_
to PTE an irrevocable, royalty -free, non -transferable, non-exclusive right and license to use, reproduce,
make derivative works, display, and perform publicly any copyrights or copyrighted material (including any computer software and its
documentation and/or databases) first developed and delivered under this Subaward solely for the purpose of and only to the extent
required to meet PTE's obligations to the Sponsor under its Prime Award.
Subrecipient grants to PTE the right to use any written progress reports and deliverables created under this Subaward solely for the
purpose of and only to the extent required to meet PTE's obligations to the Sponsor under its Prime Award.
Data Rights:
Subrecipient grants to PTE the right to use data created in the performance of this Subaward solely for the purpose of and only to
the extent required to meet PTE's obligations to the Sponsor under its Prime Award.
Data Sharing and Access (Check if applicable):
Subrecipient agrees to comply with the Sponsor's data sharing and access requirements as reflected in the Prime Award (or in
the special terms below) and the Data Management/Sharing Plan submitted to the Sponsor and I attached.
DocuSign Envelope ID: 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
Promoting Objectivity in Research (COI):
Subrecipient must designate herein which entity's Financial Conflicts of Interest policy (COI) will apply:
Subrecipient
If applying its own COI policy, by execution of this Subaward, Subrecipient certifies that its policy complies with the requirements of the
relevant Federal Awarding Agency as identified herein:
42 CFR Part 50 Subpart F
Subrecipient shall report any financial conflict of interest to PTE's Administrative Representative or COI contact, as designated on
Attachment 3A. Any financial conflicts of interest identified shall, when applicable, subsequently be reported to Federal Awarding
Agency. Such report shall be made before expenditure of funds authorized in this Subaward and within 45 days of any subsequently
identified COI.
Work Involving Human or Vertebrate Animals (Select Applicable Options)
nNo Human or Vertebrate Animals
This section left intentionally blank.
Human Subjects Data (Select One)
Not Applicable
This section left intentionally blank
Additional Terms
In connection with the performance of work under this contract, SUBRECIPIENT may not refuse to hire, discharge, promote or
demote, or discriminate in matters of compensation against any person otherwise qualified, solely because of race, color, religion,
national origin, gender, age, military status, sexual orientation, gender identity or gender expression, marital status, or physical or
mental disability. SUBRECIPIENT shall insert the foregoing provision in all subcontracts.
All invoices must also include a unique invoice number and "pay to" information in order to be paid. Invoices that do not reference
these items, as well as PTE Subaward number, shall be returned to Subrecipient.
DocuSign Envelope ID: 63C1C576-9AFB-49DB-8750-D569B4FB2ED7
i _
Attachment 3A
Pass -Through Entity (PTE) Contacts
i
Subaward Number:
Al 8 -0055 -S008 -A03
PTE Information
Entity Name:
Legal Address:
Website:
'Denver Health and Hospital Authority
_ . . _ _
777 Bannock Street
Denver, CO 80204-4057
www.denverhealth.org
PTE Contacts
Central Email:
Principal Investigator Name:
Email:
sparo@dhha.org
Judith.Shlay@dhha.org
Administrative Contact Name:
Email:
Telephone Number:
303-602-3714
Samantha Volk Jennings@dhha.org
samantha.volkjennings@dhha.org
COI Contact email (if different to above):
Financial Contact Name:
Email:
'Tamara Wilde
Telephone Number:
303-602-3526
sparo@dhha.org
Tamara.Wilde@dhha.org
Email invoices?® Yes O No Invoice email (if different):
Authorized Official Name:
Email:
Telephone Number:
303-602-7063
Nikki.Pham@dhha.org
Amanda Breeden, MA, CRA
sparo@dhha.org
Telephone Number:
303.602.7046
PI Address:
777 Bannock Street, MC
Denver, CO 80204-4057
Administrative Address:
777 Bannock Street, MC 1952
Denver, CO 80204-4057
Invoice Address:
777 Bannock Street, MC
Denver, CO 80204-4057
DocuSign Envelope ID: 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
i _
Attachment 3B
Subrecipient Contacts
i
Subrecipient Information for FFATA reporting
Entity's DUNS Name:
Subaward Number:
A18 -0055 -S008 -A03
EIN No.:
DUNS:
Parent DUNS:
Place of Performance Address
Institution Type:
Currently registered in SAM.gov: ® Yes 0 No
Exempt from reporting executive compensation:O Yes® No (if no, complete 3Bpg2)
This section for U.S. Entities:
Congressional District:
Zip Code Look -up
Zip Code+4:
Subrecipient Contacts
Central Email:
Website:
Principal Investigator Name:
N/A
Email:
Administrative Contact Name:
Email:
Financial Contact Name:
Email:
Invoice/Payment Email:
Authorized Official Name:
Email:
Telephone Number:
Telephone Number:
Telephone Number:
Telephone Number:
Legal Address:
Administrative Address:
Payment Address:
DocuSign Envelope ID: 63C1C576-9AFB-49DB-8750-D569B4FB2ED7
i _
Attachment 3B-2
Highest Compensated Officers
i
Subaward Number:
A18 -0055 -S008 -A03
Subrecipient:
Institution Name:
PI Name:
Weld County Department of Public Health and Environment
Highest Compensated Officers
The names and total compensation of the five most highly compensated officers of the entity(ies) must be listed if
the entity in the preceding fiscal year received 80 percent or more of its annual gross revenues in
Federal awards; and $25,000,000 or more in annual gross revenues from Federal awards; and the public does
not have access to this information about the compensation of the senior executives of the entity through
periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. §§
78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986. See FFATA § 2(b)(1) Internal Revenue
Code of 1986.
Officer 1 Name:
Officer 1 Compensation:
Officer 2 Name:
Officer 2 Compensation:
Officer 3 Name:
Officer 3 Compensation:
Officer 4 Name:
Officer 4 Compensation:
Officer 5 Name:
Officer 5 Compensation:
DocuSign Envelope ID: 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
Attachment 4
Reporting and Prior Approval Terms
i
Subaward Number:
Al 8 -0055 -S008 -A03 '
Subrecipient agrees to submit the following reports (PTE contacts are identified in Attachment 3A):
Technical Reports:
Monthly technical/progress reports will be submitted to the PTE's
of the end of the month.
Principal Investigator
within
15
days of
Quarterly technical/progress reports will be submitted within 30 days after the end of each project quarter to
the PTE's ( Principal Investigator I
Annual technical / progress reports will be submitted within 30 days prior to the end of each budget period
to the PTE's [Principal Investigator . Such report shall also include a detailed budget for the next Budget Period,
updated other support for key personnel, certification of appropriate education in the conduct of human subject
research of any new key personnel, and annual IRB or IACUC approval, if applicable.
A Final technical/progress report will be submitted to the PTE's Principal, Investigator within 30 days of the
end of the Project Period or after termination of this award, whichever comes first.
Technical/progress reports on the project as may be required by PTE's
to satisfy its reporting obligations to the Sponsor.
Principal Investigator
in order for the PTE
Prior Approvals:
Carryover:
Carryover is restricted for this subaward by the:
Submit carryover requests to the Financial Contact
Pass -Through Entity
Other Reports:
In accordance with 37 CFR 401.14, Subrecipient agrees to notify PTE's
days after Subrecipient's inventor discloses invention(s) in writing to Subrecipient's personnel responsible
for patent matters. The Sulvecioient will submit a fin I invention report using Sponsor
specific forms to the PTE's Authorized Official (within 60 days of the end of the Project Period to be
included as part of the PTE's final invention report to the Sponsor.
A negative report is required: No
Property Inventory Report (only when required by Sponsor), specific requirements below.
Authorized Official
Other Special Reporting Requirements:
30
DocuSign Envelope ID: 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
i _
Attachment 5
Statement of Work, Cost Sharing, Indirects & Budget
i
Statement of Work
Attached,
pages
Subaward Number:
A18 -0055 -S008 -A03
If award is FFATA eligible and SOW exceeds 4000 characters, include a Subrecipient Federal Award Project Description
Budget Information
Indirect Information Indirect Cost Rate (IDC) Applied
Rate Type:
Modified Total Direct Costs
19.29
OA
Cost Sharing
No
If Yes, include Amount: $
Budget Details O Below
Attached,
pages
Budget Totals
Direct Costs $
Indirect Costs $
Total Costs $
22,414.00
4,324.00
126, 738.00
All amounts are in United States Dollars
DocuSign Envelope ID: 63C1C576-9AFB-49DB-8750-D569B4FB2ED7
Subaward Number:
Al 8 -0055 -S008 -A03
O
Attachment 6
Prime Award and any additional documents
The following pages include the Prime Award and if applicable any additional documentation
referenced throughout this Subaward.
Not incorporating the Prime Award or any additional documentation to this Subaward.
DocuSign Envelope ID: 63C1C576-9AFB-49DB-8750-D569B4FB2ED7
WELD COUNTY DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT
SCOPE OF WORK
This scope of work applies to the Cancer, Cardiovascular, and Chronic Pulmonary Disease Program (CCPD)
with grant monies received from the Colorado Department of Public Health and Environment.
Amount: $26,738
Period of Performance: July 01, 2022 — June 30, 2023
Definitions:
1. ACCORDS: Adult and Child Consortium for Health Outcomes Research and Delivery Science
2. ACIP: The Advisory Committee on Immunization Practices
3. Advisory Council: The Alliance Advisory Council is a group of subject matter experts who contribute to
identifying gaps, new needs, and growth for our project. The Advisory Council's goal is to strengthen interagency
connections by aligning stakeholder goals and strategies that address challenges to increased HPV vaccination
rates.
4. AFIX: Assessment, Feedback, Incentives, and eXchange Program from the Centers for Disease Control and
Prevention (CDC) is an immunization quality improvement (QI) process designed to increase immunization
coverage rates, decrease missed opportunities to vaccinate, and improve standards of immunization practices at the
provider clinic level.
5. Alliance: The Alliance for HPV Free Colorado; this collaborative Alliance is comprised of grant subcontractors,
state and local immunization programs, public and private health providers, academic institutions, medical
societies, professional organizations addressing immunizations and cancer prevention, youth -serving
organizations, and immunization advocacy groups. The Alliance encompasses all committees and groups on our
project.
6. Alliance Communications Committee: The Communications Committee will develop and implement a regional
public information campaign and provide quarterly reports to the Alliance.
7. Alliance Dental Workgroup: The Dental Workgroup will oversee development of the framework and materials to
help dentists improve their support of the HPV vaccine.
8. Alliance Health Systems Committee: The Health Systems Committee will oversee, create, and implement a plan to
help health systems utilize quality improvement approaches to engage providers and strengthen their
recommendation for HPV vaccination.
9. Alliance Education Workgroup: The Education Workgroup will oversee development of provider education series,
training of local public health departments, and implementation of practice intervention
10. Alliance Rural/Frontier Adaptation Workgroup: The Rural/Frontier Adaptation Workgroup will oversee adaptation
of communications and health systems materials for rural and frontier Colorado.
11. Alliance Steering Committee: The Steering Committee exists to oversee, manage, and guide the overall grant,
including the work of the Advisory Council and all subcommittees.
12. BCPH: Boulder County Public Health
13. CCC HPV Task Force: Colorado Cancer Coalition HPV Vaccination Task Force
14. CCPD: Cancer, Cardiovascular Disease, and Pulmonary Disease Grants Program
15. CDC: Centers for Disease Control and Prevention
16. CDPHE: Colorado Department of Public Health and Environment
17. CIIS: Colorado Immunization Information System
18. DHHA: Denver Health and Hospital Authority
19. Fifteen county jurisdiction: Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, Jefferson, Larimer, Logan,
Morgan, Phillips, Sedgwick, Washington, Weld and Yuma counties
20. HPV: Human Papillomavirus
21. IC: Immunize Colorado
22. JCPH: Jefferson County Public Health
23. LPHA: Local Public Health Agency
24. NCHD: Northeast Colorado Health Department
25. Outreach Roadmap: Document outlining plan for reaching out to and gaining buy -in from health systems partners
that may be interested in working with the Alliance to improve vaccination rates.
26. PHIDH: Public Health Institute at Denver Health
27. QI: Quality Improvement
28. RCCOs/RAEs: Regional Care Collaborative Organizations/Regional Accountable Entities
29. SMART: Specific, Measurable, Achievable, Realistic, and Timely
30. WCDPHE: Weld County Department of Public Health and Environment
DocuSign Envelope ID 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
Quarter; timelines
Quarter 1 July 1 -September 30
I Quarter 2 October 1 -December 31
Quarter 3 January 1 -March 31
Quarter 4 April 1- June 30
Project Title Alliance for HPV Free Colorado
Pnncipal Investigator Judith Shlay
Program Coordinator Samantha Volk Jennings
As a sub -contractor of DHHA, WCDPHE will perform the following scope of work related to the
implementation and ongoing management of the CCPD grant "Alliance for HPV Free Colorado "
Scope of work assignments are delineated by the approved HPV Alliance work plan for the following objectives
and activities of the project Deliverables are the responsibility of the staff appointed by WCDPHE
Goal No later than the expiration date of this contract, the Alliance for HPV Free Colorado aims to implement a
multidisciplinary approach that results in a sustainable increase in completion of the HPV vaccine senes for 9-
17 year -olds in a fifteen county region
Our four objectives are to
1 Utilize (community and partner stakeholders, including an HPV Advisory Council, to promote
and champion HPV vaccine education and awareness,
2 Plan and implement a health systems approach to increase adherence to national HPV
vaccination Iguidehnes among practices and providers,
3 Adapt and implement a targeted communications plan to increase demand for and knowledge
about the HPV vaccine among parents/guardians of adolescents aged 9-17 years, and
4 Utilize sustainable analytic infrastructure to measure HPV vaccination rates
Work Plan
Objective #1
Utilize community and partner stakeholders, including an HPV Advisory Council, to
promote and champion HPV vaccine education and awareness
Primary Activity #1
(Steering Committee) `"
The Subcontractor shall participate in the Alliance Steering Committee and complete
applicable administrative activities
f Sub -Activities
j ' I
1 The Subcontractor shall participate in regularly scheduled Steering Committee
meetings and complete resulting meeting action items as assigned
2 The Subcontractor shall participate in project strategic planning sessions
3 The Subcontractor shall participate in regular Alliance subcommittee engagement and
satisfaction surveys
4 The Subcontractor shall provide data for project evaluation reports as requested
5 The Subcontractor shall support the Alliance in updating project sustainability plan
�°�✓ > kWRP*1 fiu ,10KV,rir ,., b':Sri� 'far . G .; sts (;VA:� Y, .:; -td. t, :v . 1 k , u , 0 X i e r s Z R 5.1 _ §' ,
Primary Activity #2 - '
' (Advisory Council)
The Subcontractor shall participate in the Alliance Advisory Council
Sub -Activities
_
1 The Subcontractor shall attend regularly scheduled quarterly HPV Advisory Council
meetings, including subcommittee members as requested
2 The Subcontractor shall plan, prepare, and facilitate agenda items if requested
3 The Subcontractor shall complete the Advisory Council member engagement survey
_ ` ,
Objective #2
4
Adapt and implement a health systems approach to increase adherence to national HPV
vaccination guidelines among practices and providers
DocuSign Envelope ID 63C1C576-9AFB-49DB-B750-D569B4FB2ED7
Primary Activity #1
(Health, Systems) "
The Subcontractor shall assist in implementing a health systems approach to increase
adherence to national HPV vaccination guidelines among practices and providers
i ,
s
1
1`
,
_
Sub -Activities -
, ar ,
-
1 The Subcontractor shall participate in regularly scheduled Health System Committee
meetings
2 The Subcontractor shall support LPHAs in connecting with, identifying, and targeting
- health systems using the outreach roadmap
3 The Subcontractor shall act as a Health System Facilitator and work with Health
Systems committee to outreach to a minimum of ten (10 ) public and private schools,
community colleges, and/or public and private universities and colleges to participate
in onsite events to promote and offer HPV vaccinations, and to provide education to
staff, students, and other community members on the benefits of the HPV vaccine
4 The Subcontractor shall act as a Health System Facilitator and work with Health
Systems committee to connect HPV Free Colorado with the appropriate staff at a
minimum of seven (7) new or previously engaged public and private schools,
community colleges, and/or public and private universities and colleges to support
initiation of quality improvement intervention projects
5 The Subcontractor shall help update the outreach roadmap based on feedback from 1
health systems and committee members
6 The Subcontractor shall identify training needs for individuals who will be working
with health systems to inform a training guide for effectively guiding systems on HPV
vaccination best practices
7 The Subcontractor shall help update the implementation plan based on feedback from
health systems and committee members
8 The Subcontractor shall help finalize and execute the health systems evaluation plan
dJs�oT r T ; Y,,�f( 4 �{ n
..2 Ph BAs "f.'�'
T. -y 4 A4 a�*3
nt jY Y
lS , Y {>ys t
�.1 rZ'"" 'fib^'�+9"W�4
(�y ,;� k F y� i
4 -•."x b,9 .ti,?�'v � !gYixa
st{ W'vtt SSi .r, '- %6
�^-,....6)-rysr "st; fry 1 i� ' l , 5 '� ar J_. .t }' l am ¢4� N PR S
t„'i 1�' lrv`% dY'.. 8,,,i 3r.3 7tY.
� hs „�•t✓ e n Y'm i„
Ysfi `f� .�r S. r �+-r'"2 v`'' tea:
�� Y� ni` t YAP°�K3t y " # ` A t" ' fHs� vt',,jj
1{ r'" '@"1:2�rf�+•�e�0��q.'.4lrlFJtry �Y �4.S�',x'?o+�'�r 1..�^rg'K'ryP �lF J^��1�.�FY .� %�.�Y.i �>
w
f� LY i` '"° �NL S -'H j3 �fY`t 1N" tKJ�`e "T !F 'Q
�" 'y` y±V�� `4�, A6 + d
b""1 ��^?#' '',, it':
s i,,� �' ,�C tp� 1 �.p $ �,y, 5 d .. 6„ q, l₹ .0 � R i �,v-,y�, .s �
1iW r'I t./Z�.'.s �'�1 X56 +V ^.'rb°M1�D"�i r'C 2.v4 .�'� FR F"'4.;C 'e iP'JS+' .£i< i' ' 5`l, 'l '� ic4^."•{ui $fi'.,�`Y Ftth �f
,
Primary Activity #2 ,
(Education)''' '
The Subcontractor shall participate in regularly scheduled Education Workgroup
meetings
,
L
- -
' Sub -Activities- -
1 The Subcontractor shall support adaptations to educational materials and keep up to
date on most recent HPV-related research and information
,2 The Subcontractor shall help plan and host a minimum of three (3) education events
with the workgroup This excludes trainings in conjunction with health systems
engaged in QI projects
3 The Subcontractor shall participate in a minimum of two (2) engagement activities
(conference attendance, stakeholder meetings, etc ) to increase engagement with
health systems outside of the formal education efforts
4 The Subcontractor shall collect and input relevant survey data after trainings are
complete
5 The Subcontractor shall help lead education training sessions with Workgroup
members, as needed
6 The Subcontractor shall collaborate with the Health Systems Committee to create,
adapt, and provide education and materials for Health Systems Committee partners
7 The Subcontractor shall collaborate with the Health Systems Committee to provide
framing for identified health systems' staff and providers engaging in the HPV work
'Objective #3 _
' ` �
Adapt and implement a targeted communications plan to increase demand for and
knowledge about the HPV vaccine among parents/guardians of adolescents aged 9 -17
years
Primary Activity #1
(Communications) ,
The Subcontractor shall participate in regularly scheduled Communications Committee
meetings
DocuSign Envelope ID: 63C1 C576-9AFB-49DB-B750-D569B4FB2ED7
Sub -Activities
1. The Subcontractor shall review results of the paid, earned, and owned media
campaigns metrics and offer recommendations for improvements.
2. The Subcontractor shall assist in planning and implementing an evaluation of the paid
media campaign.
3. The Subcontractor shall review the results of the evaluation and offer
recommendations for improvements.
4. The Subcontractor shall use results from research to provide input on updating
marketing campaign.
5. The Subcontractor shall participate in reviews of requests to share the campaign with
other organizations on a case -by -case basis.
6. The Subcontractor shall participate in campaign dissemination efforts, such as
presentations, phone calls, or articles.
7. The Subcontractor shall be prepared to and will take on specific duties of the
Committee Chair, as agreed upon by the Committee, should the Chair fall sick, go on
vacation or otherwise be unable to execute their duties during a specific period of time.
8. The Subcontractor shall support the Health Systems Committee, Dental Workgroup,
and Education Workgroup in executing relevant communications materials.
Objective #4
Utilize sustainable analytic infrastructure to measure HPV vaccination rates.
Primary Activity #1
(Everyone)
The subcontractor shall assist with utilization, maintenance, and sustainability planning of
IBIS.
Sub -Activities
1. The Subcontractor shall provide analytic consulting expertise as needed.
2. The Subcontractor shall assist with reviewing and interpreting data reports for
subcommittees' use, including evaluation, population -level, and practice -level reports.
3. The Subcontractor shall provide feedback on an IBIS sustainability plan, assessing
future of IBIS and HPV data needs.
4. The Subcontractor shall provide feedback on exploring effectiveness of using CIIS and
IBIS to track health system level data.
Deliverables:
Steering Committee
The Subcontractor shall submit an
electronic Progress Report to the
Program Coordinator when
requested.
No later than 5 days before end of
Q1, Q2, Q3, and Q4.
The Subcontractor shall submit
responses to all participant
engagement and satisfaction surveys
following Advisory Council and
relevant Alliance committees and
workgroups.
No later than 5 days before end of
Q2 and Q4.
The Subcontractor shall submit
feedback on the population -level
HPV vaccination reports
No later than 5 days before end of
Q4.
Health Systems
The Subcontractor shall submit the
names and locations of the health
systems invited and committed to
working with Alliance.
No later than 5 days before end of
Q1, Q2, Q3, and Q4.
The Subcontractor shall submit
feedback on materials created for
effectively guiding systems on HPV
vaccination best practices.
No later than 5 days before end of
Q2, Q4.
The Subcontractor shall submit
feedback on final health systems
evaluation report.
No later than 5 days before end of
Q4.
DocuSign Envelope ID: 63C1 C576-9AFB-49DB-B750-D569B4FB2ED7
Communications
The
feedback
evaluation
earned,
Subcontractor
on
and
results
pre
owned
-campaign
and
shall
submit
final
plans.
paid,
No
Q2.
later
than
5 days
before
end
of
media
The
feedback
evaluation
earned,
Subcontractor
on
and
results
owned
pre
-campaign
shall
submit
final
reports.
paid,
No
Q4.
later than
5 days
before
end
of
and
media
The
feedback
report.
Subcontractor
on
the
website
shall
submit
usage
No
Q4.
later
than
5 days
before end
of
local
The
feedback
created
Subcontractor
media
by
on
community
materials
efforts
shall
used
advocates
submit
and
in
No
Q2
later
and
than
Q4.
5 days
before
end of
The
feedback
for
advocates
Subcontractor
English
on
and
training
shall
Spanish
materials
submit
speaking
used
No
Q
1.
later
than
5 days
before end
of
Method of Accountability: Subcontractor will attend meetings and submit quarterly progress reports when
requested.
Budget:
Weld County Dept Public Health & Environment
Alliance for HPV Free CO
July 1, 2022- June 30, 2023
Personnel
Position
Health Educator/Navigator
Office Technician
Program Supervisor
Subtotal Salaries
Salary
$62, 526
$41,128
$89, 602
$193,256
Fringe (39.45%)
$24,667
$16,225
$35,348
$76,239
% Effort
14%
5%
3%
# months
12
12
12
Cost
$12,207
$2, 86€
$3,74E
$18,822
Other Expenses
Mileage -Trainings (1-2 per yr), Meetings (8-10 per yr), Provider education (4-6
per yr).
Office/Other Operating Supplies
Supplies: markers, poster paper, pens, photocopies and other training supplies
Educational Material - Brochures etc
Media
ISubtotal Other
Cost per #
$0.565
$10
$50
$0.50
$1,000
40
4
10
57
3
$23
$40
$500
$29
$3,000
$0
$3,591
Total Direct Cost (TDC)
$22,414
Indirect @ 19.29%
$4,324
Tota 1
$26,738
Contract Form
New Con ct Begin
Entity Name*
DENVER HEALTH AND HOSPITAL
AUTHORITY
Entity ID*
@00015139
Contract Name*
DENVER HEALTH ALLIANCE FOR HPV FREE COLORADO
Contract Status
CTB REVIEW
❑ New Entity?
D Parent Contract ID
6032
Contract Lead*
KJAKUS-HOTCHKISS
Contract Lead Email
kjakus-
hotchkiss@weldgov.com
Requires Board Approval
YES
Department Project
Contract Description*
DENVER HEALTH & HOSPITAL AUTHORITY ALLIANCE FOR HPV FREE COLORADO FY22-23 EDP REIMBURSEMENT SUBAWARD
AGREEMENT Al 8-0055-5008-A03
Contract Description 2
FY21-22 SUBAWARD AGREEMENT Al 8 -0055 -S008 -A02; FY20-2 i SUBAWARD AGREEMENT Al 8 -0055 -S008 -A01
Contract Type
AGREEMENT
Amount*
$26,738,00
Renewable*
NO
Automatic Renewal
NO
Grant
YES
IGA
NO
If this is a r
5080
If this is:
a
Department
HEALTH
nt it
CM-Healthwweldgov.com
nt Head Email
CM-Health-
DeptHeadgweldgov.com
County Attorney
GENERAL COUNTY
A I I ORNEY EMAIL
County Attorney Email
CM-
COUNTYA I I ORN EYAIELDG
OV.COM
Grant Deadline Date
previous Contract ID
enter MSA Contract ID
Requested BOCC t nda Due Date
Dater 06/23,2022
06;27/2022
Will a work session with BOCC be required?*
NO
Does Contract require Purchasing Dept. to be included?
Note: the Previous Contract Number and Master Services Agreement Number should be left blank if those contracts are not in
OnBase
Contract Date,
Effective Date
07/0112022
Termination Notice Period
O Ct Int t10
antact into
chasm
Pr rc ce5
Head
TANYA GEISER
OH Approved Date
06/21/2022
P
BOCC Approved
BOCC Signed Date
BOCC Agenda Dale
06,3`27,,, 2022
Originator
KJAKUS-HOTCHKISS
Review Date*
03,!31 ,!2023
Committed mitted Delivery Date
Contact Type
Finance Approver
CHERYL PA I I ELLI
Renewal Date
Expiration Date
06/3012023
Contact Phone 1
Purchasing Approved Date
Finance Approved Date
06/2112022
Tyler Ref #
AG 062722
Legal Counsel
BRUCE BARKER
Legal Counsel Approved Date
06/2212022
Hello